GlassScriptPhysician profile
Laura Hampel
NPI 1013366426
$928.13
in general payments reported to CMS, 2019-2025
14 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $324 · 2023: $253 · 2024: $234 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $603.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $205.46 | 2022-2023 | Ova1 |
| Gynesonics, INC. | $164.00 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $149.33 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $91.08 | 2022-2025 | |
| Hologic Sales and Service, LLC | $60.31 | 2022-2023 | Acessa Provu System |
| Therapeuticsmd, INC. | $52.45 | 2022 | |
| Abbvie INC. | $45.89 | 2022-2023 | |
| Organon LLC | $32.84 | 2022-2024 | |
| Exact Sciences Corporation | $31.84 | 2023-2025 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $27.33 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $19.93 | 2023 | Accrufer |
| Coopersurgical, INC. | $16.94 | 2024 | Paragard T 380a |
| Pfizer INC. | $15.93 | 2023 | |
| Sumitomo Pharma America, INC. | $14.80 | 2024 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Hampel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.